Literature DB >> 10754948

High prevalence of genital Chlamydia trachomatis infection in women presenting in different clinical settings in Jamaica: implications for control strategies.

G Dowe1, M Smikle, S D King, H Wynter, J Frederick, T Hylton-Kong.   

Abstract

OBJECTIVE: To determine the prevalence of genital Chlamydia trachomatis infection and risk factors in women attending family planning, gynaecology, and sexually transmitted disease (STD) clinics in Jamaica.
METHODS: Endocervical specimens from 645 women including 238 family planning, 170 gynaecology, and 237 STD clinic attendees were examined for C trachomatis using a direct fluorescence assay (DFA) and culture. Investigations were carried out for the presence of other STD pathogens and demographic, behavioural, historical, and clinical data recorded for each participant.
RESULTS: The prevalence of C trachomatis infection was 35%, 47%, and 55% in family planning, gynaecology, and STD clinic clients, respectively. The performance of the DFA was comparable to that of culture in screening for C trachomatis. Logistic regression analysis revealed that the independent risk factors for C trachomatis infection were non-barrier contraceptive methods in family planning clients (OR = 2.1; 95% confidence interval (CI) = 1.2-3.9; p = 0.0110), cervical ectopy in gynaecology clients (OR = 3.9; 95% CI = 1.4-10.6; p = 0.0076) and concomitant Trichomonas vaginalis infection in STD clients (OR = 3.5; 95% CI = 1.8-6.8; p = 0.003). Age, number of sex partners, and reason for visit were not identified as risk factors for C trachomatis infection.
CONCLUSIONS: Consistently high prevalence of C trachomatis infection occurs in Jamaican women. Universal screening or presumptive treatment should be evaluated as prevention and control measures for C trachomatis infection in this population where all women appear to be at risk.

Entities:  

Mesh:

Year:  1999        PMID: 10754948      PMCID: PMC1758250          DOI: 10.1136/sti.75.6.412

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  17 in total

1.  Disease prevalence among women attending a sexually transmitted disease clinic varies with reason for visit.

Authors:  K M Pabst; C A Reichart; C R Knud-Hansen; J N Wasserheit; T C Quinn; K Shah; G Dallabetta; E W Hook
Journal:  Sex Transm Dis       Date:  1992 Mar-Apr       Impact factor: 2.830

2.  Chlamydia trachomatis infection in women attending urban midwestern family planning and community health clinics: risk factors, selective screening, and evaluation of non-culture techniques.

Authors:  D G Addiss; M L Vaughn; R Golubjatnikov; J Pfister; D F Kurtycz; J P Davis
Journal:  Sex Transm Dis       Date:  1990 Jul-Sep       Impact factor: 2.830

3.  Cost-benefit analysis of selective screening criteria for Chlamydia trachomatis infection in women attending Colorado family planning clinics.

Authors:  J T Humphreys; J F Henneberry; R S Rickard; J L Beebe
Journal:  Sex Transm Dis       Date:  1992 Jan-Feb       Impact factor: 2.830

4.  Selective screening for Chlamydia trachomatis infection in a primary care population of women.

Authors:  A Stergachis; D Scholes; F E Heidrich; D M Sherer; K K Holmes; W E Stamm
Journal:  Am J Epidemiol       Date:  1993-08-01       Impact factor: 4.897

5.  Prevalence of viral and bacterial sexually transmitted pathogens in Jamaican pregnant women.

Authors:  G Dowe; S D King; M F Smikle; H H Wynter; R Chout; W Klaskala
Journal:  West Indian Med J       Date:  1998-03       Impact factor: 0.171

6.  Screening for Chlamydia trachomatis infection in a sexually transmitted disease clinic: comparison of diagnostic tests with clinical and historical risk factors.

Authors:  G P Kent; H R Harrison; S M Berman; R A Keenlyside
Journal:  Sex Transm Dis       Date:  1988 Jan-Mar       Impact factor: 2.830

7.  Chlamydia trachomatis infection in women: a need for universal screening in high prevalence populations?

Authors:  H S Weinstock; G A Bolan; R Kohn; C Balladares; A Back; G Oliva
Journal:  Am J Epidemiol       Date:  1992-01-01       Impact factor: 4.897

8.  Chlamydial infections in selected populations in Jamaica.

Authors:  S D King; G Dowe; H H Wynter; A R Brathwaite
Journal:  West Indian Med J       Date:  1992-12       Impact factor: 0.171

9.  Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic.

Authors:  L S Magder; H R Harrison; J M Ehret; T S Anderson; F N Judson
Journal:  Am J Epidemiol       Date:  1988-08       Impact factor: 4.897

10.  Prevalence of Chlamydia trachomatis in women attending a family planning clinic in Papua New Guinea.

Authors:  J J Theunissen; G Kariwiga; J M Ossewaarde; J H van Rijsoort-Vos; E Stolz; W I van der Meijden
Journal:  Genitourin Med       Date:  1995-10
View more
  5 in total

1.  Notice of redundancy.

Authors: 
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

2.  Hormonal contraception and area of cervical ectopy: a longitudinal assessment.

Authors:  Patricia L Bright; Abigail Norris Turner; Charles S Morrison; Emelita L Wong; Cynthia Kwok; Irina Yacobson; Rachel A Royce; Heidi O Tucker; Paul D Blumenthal
Journal:  Contraception       Date:  2011-03-23       Impact factor: 3.375

3.  Biological and behavioral risks for incident Chlamydia trachomatis infection in a prospective cohort.

Authors:  Loris Y Hwang; Yifei Ma; Anna-Barbara Moscicki
Journal:  Obstet Gynecol       Date:  2014-11       Impact factor: 7.661

4.  Prevalence and risk factors for Chlamydia trachomatis infection in adolescent females and young women in central Brazil.

Authors:  R S C Araújo; E M B Guimarães; M F C Alves; E Sakurai; L T Domingos; F C R Fioravante; A C S Machado
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-06       Impact factor: 3.267

5.  Urogenital Chlamydia trachomatis infections among ethnic groups in Paramaribo, Suriname; determinants and ethnic sexual mixing patterns.

Authors:  Jannie J van der Helm; Reinier J M Bom; Antoon W Grünberg; Sylvia M Bruisten; Maarten F Schim van der Loeff; Leslie O A Sabajo; Henry J C de Vries
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.